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Abstract: Human endometrial stem cells (hESCs) are mesenchymal stem cells, which are responsible for the monthly renewal of the
basal layer of the human endometrium by facilitating stromal and vascular regeneration. In this study, hESCs were isolated by using
three different isolation methods including nonenzymatic and enzymatic digestion with trypsin and collagenase type 1. To determine
the efficiency of these three methods, cells were characterized using a cell proliferation assay and mesenchymal and hematopoietic
stem cell markers. Our results demonstrate that although the nonenzymatic isolation method gave rise to hESCs that had a higher
proliferative rate, the mesenchymal stem cell profiles for hESCs isolated with three methods were similar, with no significant difference
for the early passages. However, late passage hESCs isolated using trypsin showed a CD31highCD44low profile. Similarly, when hESCs
isolated with the nonenzymatic method were kept until late passage, they demonstrated a CD31high profile with a significant decrease
in CD90, CD73, CD44, and CD105 surface expression levels. Only hESCs isolated with collagenase type 1 did not present a significant
shift in their mesenchymal CD marker profile from early to late passages, suggesting that the long-term maintenance of mesenchymal
markers could only be achieved in cell isolation with collagenase type 1.
Key words: Isolation methods, endometrium, endometrial stem cells

1. Introduction
The human endometrium is a dynamic tissue that
undergoes
differentiation,
regeneration,
cellular
proliferation, and breakdown at each menstrual cycle
during women’s reproductive years (Figueira et al., 2011).
It has the ability to grow from 0.5–1 mm in thickness at the
initial stage to 5–7 mm in thickness after each menstrual
cycle. In addition, endometrial regeneration occurs in
postmenopausal women on estrogen replacement therapy
(Ulrich et al., 2014). Likewise, hemopoietic tissue, the
epidermis, and the intestinal epithelium have a similar
regeneration capacity (Pittenger et al., 2009).
Adult stem cells are stem cells found in the majority of
organs and tissues in adult organisms and they are known
to function in long-term tissue maintenance and repair due
to their ability to differentiate into a number of different
cell types found in their tissue of residence (Romanov et
al., 2005; Pittenger et al., 2009). According to the studies
conducted by Gargett et al. (2006, 2009), the regenerative
capacity of the human endometrium is driven by the

endometrial stem/progenitor cells that reside in the basal
layer of the human endometrium, which are responsible
for the monthly stromal and vascular regeneration. Human
endometrial stem cells (hESCs) show progenitor celllike properties including differentiation and proliferation
capacity and carry enormous potential for estrogenic,
myogenic, adipogenic, and chondrogenic differentiation
(Gargett et al., 2010; Ai et al., 2012; Miyazaki et al., 2012).
Studies about hESC markers show that endometrial
stem cells showed a similar CD marker profile to the
bone marrow-derived mesenchymal stem cells (Wang
et al., 2012). Subsequent research identified CD146 and
PDGF-Rβ as two specific endometrial stem cell markers
in addition to CD90, CD73, CD105, CD31, CD44, CD29,
CD14, and integrin beta 1 (Spitzer et al., 2012; Verdi et al.,
2014).
The first study about the isolation of stem cells from
the human endometrium used enzymatic digestion of
endometrium biopsy samples with trypsin (Gargett et
al., 2006). On the other hand, another study showed
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that collagenase type 1 digestion used for the isolation of
mesenchymal stem cells from the human endometrium
yielded higher total cell number than other methods such
as hyaluronidase digestion (Verdi et al., 2014). A recent
study showed that isolation of hESCs using trypsin led
to higher efficiency when compared to the nonenzymatic
isolation of these cells from endometrial biopsy (Figueira
et al., 2011). However, there is no study that compares the
isolation efficiencies of hESCs from human endometrium
biopsy samples by using collagenase type 1, trypsin,
and scalpel mincing. Therefore, in our current study, we
compared the efficiencies of these two enzymatic isolation
methods with nonenzymatic harvest with respect to the
hESC yield in the obtained cell populations. In this context,
cell populations obtained using three different methods
were analyzed for CD90, CD73, CD44, CD105, integrin
beta 1, and CD29 (positive) and CD31, CD45, CD34, and
CD14 (negative) using a flow cytometer for the early and
late passages.
2. Material and methods
2.1. Nonenzymatic isolation of hESCs
The study protocol was approved by the Yeditepe
University Research and Ethics Committee. Five different
human subjects were involved in the study.
To avoid genetic heterogeneity, endometrium biopsies
were taken from same donor and divided into three pieces
to be subjected to three different isolation methods.
Human endometrial biopsy tissue rinsed in PBS solution
(Invitrogen, GIBCO, UK) containing 1% antibiotics was
cut with two sterile scalpel blades using a crisscrossing
motion until the tissue was finely minced. The sample
was resuspended in complete Dulbecco modified Eagle
medium (DMEM) supplemented with 10% fetal bovine
serum (FBS), 2 mM L-glutamine, and 100 U/mL penicillin
and 100 µg/mL streptomycin (Invitrogen, GIBCO).
Finely minced tissue was placed into a T75 flask (BIOFIL,
TCP, Switzerland) and incubated for 2 days to allow cell
migration from the tissue onto the tissue culture plastic
at 37 °C under humidified conditions and 5% CO2/95%
air. To remove the minced tissue, the cell monolayer was
washed with fresh growth medium and the formation of
colonies was observed for 7 days. Five different human
subjects were involved in the study. Analysis of CD markers
for early and late passages of endometrial stem cells were
performed once for each donor, making five experiments
in total. Therefore, our results were not affected by genetic
heterogeneity between donors. Early passage cells indicate
hESCs at passage 3 while late passage cells indicate hESCs
at passage 8.
2.2. Enzymatic isolation of hESCs by using trypsin
The endometrium biopsy sample was transferred into 10
mL of PBS containing 0.05% trypsin (Invitrogen, GIBCO)
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and incubated in a shaking water bath at 37 °C with the
speed of 50 × g for 1 h. After the digestion step, the cell/
trypsin solution was centrifuged at 400 × g for 5 min and
the supernatant was discarded. The pellet was resuspended
in complete DMEM and seeded into a tissue culture flask
until cells reached confluency of 80%.
2.3. Enzymatic isolation of hESCs by using collagenase
type 1
The human endometrium sample was transferred into
10 mL of PBS containing 5 mg/mL collagenase type 1
solution (Invitrogen, GIBCO) and incubated in a shaking
water bath at 37 °C with the speed of 50 × g for 1 h. After
the incubation step, the tissue suspension was centrifuged
at 400 × g for 5 min and the supernatant was discarded.
The resulting pellet was resuspended one more time in
0.5% collagenase type 1 solution in PBS and incubated in
a shaking water bath at 37 °C with the speed of 50 × g for
90 min. After incubation, cells were spun down at 400 × g
for 10 min, and the cell pellet was resuspended in complete
DMEM and seeded in a tissue culture flask (Invitrogen,
GIBCO) as indicated above.
2.4. Culturing and characterization of hESCs
A subculture process was applied when the outgrowth was
sufficient (80%–90% confluency). Cells were maintained
in complete DMEM up to passage 10 and characterized
for the expression of CD cell surface markers at passages
3 (early) and 8 (late) according to the protocol described
previously (Tasli et al., 2013). Cell surface CD antigens,
CD90 (Abcam, USA), CD73 (Abcam), CD44 (Abcam),
CD105 (Abcam), integrin beta 1 (Abcam), CD29
(Biolegend, USA), CD31 (Abcam), CD45 (Abcam), CD34
(Abcam), CD14 (Abcam), and a FITC-labeled mouse IgG1
control were used for the characterization of hESCs. Cells
were fixed with 2% paraformaldehyde in PBS for 16 hours at
4 °C. Following the fixation, the cell pellet was washed with
PBS twice and incubated with fluorescein-isothiocyanate
(FITC)- or phycoerythrin (PE)-conjugated antibodies at 4
°C for 1 h. Following another set of washes, samples were
resuspended in PBS, and the CD expression profiles were
identified using a Becton Dickinson FACSCalibur flow
cytometer and analyzed with the CellQuestPro program
(Becton Dickinson, USA).
To compare the proliferation index of hESCs isolated
by the three different methods, cells were seeded on 96well plates (2500 cells/well) at the indicated passages and
the cell number was determined using the MTS assay at 24,
48, and 72 h in reference to a standard curve as described
by the manufacturer’s protocol (Sigma-Aldrich, USA).
3. Results
The comparison of cell proliferation rates among early
passage hESCs isolated using the enzymatic trypsin
and collagenase type 1 methods and the nonenzymatic
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method demonstrated that all three types of cell isolation
protocols produced cell populations with statistically
similar proliferative rates at 24 h (Figure 1A). However,
when compared to hESCs isolated using trypsin, hESCs
that was isolated by the nonenzymatic method (P = 0.03)
and collagenase type 1 (P = 0.001) displayed a 1.8-fold
increase in the doubling time at the end of 48 h. While
no statistically significant difference was detected between
hESCs isolated by enzymatic digestion, hESCs obtained
using the nonenzymatic method showed 1.5-fold increase
in the cell number (P = 0.04) at the end of 48 h. Similarly,
when the cell proliferation rates for the late passage cells
were analyzed, it was seen that hESCs isolated by the

nonenzymatic and trypsin methods exhibited the highest
rate of cell proliferation when compared to cells obtained
through collagenase type 1 digestion at all time points (P
= 0.007; Figure 1B).
Cell populations obtained using enzymatic isolation
with trypsin were analyzed for CD90, CD73, CD44,
CD105, integrin beta 1, CD29, CD31, CD45, CD34, and
CD14 using the flow cytometer for the early and late
passages.
The early passage hESCs prepared by trypsin digestion
method were positive for mesenchymal cell surface
markers CD 90, CD73, CD44, CD105, integrin beta
1, and CD29 and negative for hematopoietic markers

Figure 1. Analysis of cell proliferation for hESCs isolated using trypsin digestion, the
nonenzymatic method, and collagenase type 1 digestion at passage 3 (A) and passage
8 (B). Cells synchronized by serum starvation were seeded into 96-well plates and
allowed to attach overnight. MTS assay was performed at 24, 48, and 72 h and cell
number was analyzed by correlating absorbance value to the cell number with the help
of a standard plate run in parallel with each experiment.
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CD31, CD45, CD34, and CD14 (Table 1). The hESCs
expressed 99.74% CD90, 99.97% CD73, 99.83% CD44,
99.89% CD105, 95.33% integrin beta 1, and 99.38% CD29
mesenchymal specific markers and 0.88% CD34, 3.90%
CD45, 0.10% CD14, and 0.32% CD31 at the third passage
(Figure 2). These cells demonstrated the highest level
of gated % values for the CD73 and CD105 markers. In
the later passage hESCs isolated with trypsin showed a
higher expression for the hematopoietic and endothelial
marker CD31 (35.59%) and a lower expression for the
mesenchymal marker CD44 (17.84%) when compared to
their low passage counterparts (Table 2). These cells also
demonstrated a decrease in the expression percentage of
mesenchymal CD markers such as CD90 (62.44%), CD73
(64.72%), and CD105 (60.3%), while that of integrin beta
1 (91.11%) and CD29 (97.50%) remained approximately
the same (Figure 3).
hESCs that were isolated by the nonenzymatic
method were also characterized for the CD marker
immunophenotype at the early and late passages (Table 1
and 2). At the third passage these cells were positive for
mesenchyme stemness markers CD90 (97.25%), CD73
(99.25%), CD44 (98.49%), CD105 (99.89%), integrin
beta 1 (91.38%), and CD29 (99.99%) and negative for
hematopoietic CD antigens CD34 (2.19%), CD45 (2.41%),
CD14 (1.67%), and CD31 (1.58%) (Figure 4). The isolation
of hESCs using the nonenzymatic method showed the
highest gated % values for CD29 and CD105 at their third
passage. Late passage hESCs obtained by nonenzymatic
isolation exhibited similar expression levels of integrin
beta 1 (81.49%) and CD29 (99.94%) while a significant
decrease of 71%, 68.93%, 53.16%, and 35.53% in CD90,
CD73, CD44, and CD105 respectively was detected when
compared to early passage hESCs. In addition, hESCs

isolated with the nonenzymatic method demonstrated a
CD31high profile at their late passage (Figure 5).
Characterization of early passage hESCs isolated by
collagenase type 1 demonstrated that these cells expressed
88.74% CD90, 90.55% CD73, 99.27% CD44, 96.92%
CD105, 99.92% integrin beta 1, 99.54% CD29, 1.38%
CD34, 2.62% CD45, 0.34% CD14, and 1.12% CD31 with
the highest gated % value recorded for integrin beta 1
(Figure 6). Passage 8 of hESCs obtained by the collagenase
type 1 digestion method showed the same CD marker
profile of >90% CD90+/CD73+/CD44+/CD105+/integrin
beta 1/CD29+ and <20% CD34-/CD45-/CD14 /CD31 as
their early passage counterparts (Figure 7).
4. Discussion
The therapeutic potential of hESCs has been increasing
day by day. Endometrial stem cells can be used for
gynecological purposes such as treatment of pelvic floor
prolapse, Asherman syndrome, endometriosis, and
adenomyosis (Figueira et al., 2011; Nagori et al., 2011;
Wolff et al., 2011; Mutlu et al., 2015). The aim of this
current study was the isolation and characterization
of mesenchymal stem cells obtained from human
endometrium using different isolation protocols including
a nonenzymatic procedure and enzymatic digestion with
trypsin and collagenase type 1. Adherent cells isolated
from human endometrium tissue were characterized by
mesenchymal stem cell surface antigens including CD 90,
CD73, CD44, CD105, integrin beta 1, and CD29 (positive)
and endothelial or hematopoietic markers CD31, CD45,
CD34, and CD14 (negative).
The research presented in this article compares the
enzymatic and nonenzymatic isolation methods for
hESCs not only in terms of the cell efficiencies but also

Table 1. Comparison of cell surface marker characterization of early passage hESCs isolated
using enzymatic and nonenzymatic isolation methods. Each row represents the percentage
expression ± standard error from 5 independent experiments.
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CD markers

Trypsin

Nonenzymatic

Collagenase type 1

CD90

98.77 ± 0.44

97.3 ± 0.27

86.41 ± 1.06

CD73

97.88 ± 0.90

99.25 ± 5.41

87.25 ± 1.42

CD105

99.88 ± 4.96

99.89 ± 6.83

96.92 ± 0.62

CD44

99.83 ± 0.89

94.90 ± 1.39

98.50 ± 0.30

CD29

97.77 ± 0.96

91.17 ± 6.21

98.94 ± 0.21

Integrin β1

97.60 ± 0.93

89.76 ± 3.26

99.76 ± 0.06

CD34

1.21 ± 0.23

2.33 ± 0.58

1.73 ± 0.18

CD45

3.27 ± 0.83

3.09 ± 0.91

1.53 ± 0.43

CD14

1.41 ± 0.68

1.44 ± 0.38

0.41 ± 0.40

CD31

1.19 ± 0.11

1.54 ± 0.51

1.57 ± 0.23
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Figure 2. Cell surface marker characterization of hESCs isolated with trypsin at passage 3. Cells were cultured for 3 passages and
labeled with antibodies against mouse IgG1 control (NC), CD90, CD73, CD44, CD105, integrin beta 1 (integrin β1), CD29, CD34,
CD45, CD14, and CD31. Histograms are representatives of five independent experiments.

the spontaneous differentiation potential of mesenchymal
stem cells to endothelial or hematopoietic lineages through
extended passages. Throughout the isolation period,
chemicals were not used due to their risk of undesirable
effects leading to reprogramming the stem cells (Zhang et
al., 2012).

Recently the human endometrium has been shown
as a new mesenchymal stem cell source for reproductive
science (Mutlu et al., 2015). Mesenchymal stem cells
from the endometrium retain the ability to differentiate
into osteoblasts, chondrocytes myocytes, and adipocytes
(Ai et al., 2012). These headways suggested that hESCs

Table 2. Comparison of cell surface marker characterization of late passage hESCs isolated using
enzymatic and nonenzymatic isolation methods. Each row represents the percentage expression
± standard error from 5 independent experiments.
CD markers

Trypsin

Nonenzymatic

Collagenase type 1

CD90

73.59 ± 9.39

33.67 ± 5.78

95.23 ± 3.61

CD73

55.23 ± 21.06

33.65 ± 10.17

99.97 ± 0.06

CD105

70.81 ± 10.53

73.62 ± 10.32

98.94 ± 0.78

CD44

39.61 ± 23.14

39.76 ± 5.97

99.33 ± 0.44

CD29

97.0 ± 0.31

97.37 ± 1.67

96.69 ± 2.50

Integrin β1

88.24 ± 5.83

86.18 ± 5.41

98.46 ± 1.16

CD34

22.15 ± 10.95

1.09 ± 0.42

2.44 ± 0.58

CD45

1.42 ± 0.85

1.27 ± 0.53

10.28 ± 0.86

CD14

0.76 ± 0.28

1.99 ± 0.30

5.38 ± 1.00

CD31

53.81 ± 14.25

65.11 ± 10.12

7.15 ± 2.29
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Figure 3. Cell surface marker characterization of hESCs isolated with trypsin at passage 8. Cells were cultured for 8 passages and
labeled with antibodies against mouse IgG1 control (NC), CD90, CD73, CD44, CD105, integrin beta 1 (integrin β1), CD29, CD34,
CD45, CD14, and CD31. Histograms are representatives of five independent experiments.

Figure 4. Cell surface marker characterization of hESCs isolated with nonenzymatic harvest at passage 3. Cells were cultured for 3
passages and labeled with antibodies against mouse IgG1 control (NC), CD90, CD73, CD44, CD105, integrin beta 1 (integrin β1),
CD29, CD34, CD45, CD14, and CD31. Each histogram is from one experiment representative of five independent experiments.
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Figure 5. Cell surface marker characterization of hESCs isolated with nonenzymatic harvest at passage 8. Cells were cultured for 8
passages and labeled with antibodies against mouse IgG1 control (NC), CD90, CD73, CD44, CD105, integrin beta 1 (integrin β1),
CD29, CD34, CD45, CD14, and CD31. Each histogram is from one experiment representative of five independent experiments.

Figure 6. Cell surface marker characterization of hESCs isolated with collagenase type 1 at passage 3. Cells were cultured for 3
passages and labeled with antibodies against mouse IgG1 control (NC), CD90, CD73, CD44, CD105, integrin beta 1 (integrin
β1), CD29, CD34, CD45, CD14, and CD31. Each histogram is from one of five representative experiments.
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Figure 7. Cell surface marker characterization of hESCs isolated with collagenase type 1 at the passage 8. Cells were cultured for 8
passages and labeled with antibodies against mouse IgG1 control (NC), CD90, CD73, CD44, CD105, Integrin beta 1 (Integrin β1),
CD29, CD34, CD45, CD14 and CD31. Each histogram is from one of five representative experiments.

can also be used in the treatment of endometriosis,
adenomyosis, and Asherman syndrome and therefore may
contribute to the development of new medical strategies
to treat infertility (Moore et al., 2008; Mutlu et al., 2015).
Herein, we analyzed the cell yield for three different hESC
isolation methods to determine the most suitable protocol
to be employed in future studies aiming to use hESCs in
regenerative medicine.
hESCs were described to display mesenchymal stem
cell properties of self-renewal, ability to differentiate, and
high proliferative potential in vitro and were characterized
to be positive for the mesenchymal stem cell markers
but negative for the hematopoietic cell surface markers
(Gargett et al., 2009). In agreement with these findings, the
primary cells that we isolated from the endometrium had
an adherent phenotype and mesenchymal morphology
associated with the expression of mesenchymal stem cell
markers and lack of hematopoietic markers.
One of the objectives of this study was to provide suitable
growth conditions for hESCs as the in vitro conditions
including harvesting and preservation procedures can lead
to clonal heterogeneity by inducing differentiation (Chan
et al., 2010; Zhang et al., 2012). Studies demonstrated
that hESCs have a tendency to decrease or increase their
regeneration efficiency depending on the seeding density and
the serum-containing medium is the best choice, ensuring
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better morphological appearance and improved longevity
(Chan et al., 2010; McLeod et al., 2010). Likewise, the study
reported by Patel et al. (2008) demonstrated that a FBSbased medium supported hESC growth with a remarkable
proliferation rate. Complete DMEM with 10% FBS was
therefore used in the maintenance of hESCs in this study.
The cell yield obtained for nonenzymatic digestion and
enzymatic digestion was found to be significantly different
in our study as hESCs isolated with the nonenzymatic
method displayed a significantly higher duplication time
when compared to those obtained through the enzymatic
digestion methods at the early passages. Early passage
hESCs isolated with three different methods displayed a
CD90+, CD73+, CD44+, CD105+, integrin beta 1+, CD29+,
CD31-, CD45-, CD34-, and CD14- profile with no significant
differences in the average expression levels of these
markers taken from five independent experiments. When
three different cell populations were subjected to serial
passage until the eighth passage, only the hESC population
isolated with collagenase type 1 retained a profile for
positive mesenchymal stem cells and negative endothelial
or hematopoietic surface markers while cells harvested
with trypsin digestion of the endometrium displayed an
increased expression value for the hematopoietic and
endothelial marker CD31 with a significant decrease in
mesenchymal stem cell surface markers CD90, CD73,
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CD44, and CD105. In particular, the hESC population
isolated with trypsin demonstrated a negative expression
profile for CD44 at the eighth passage. The late passage
group of hESCs obtained by nonenzymatic harvest not
only exhibited a decrease in the expression levels of CD90,
CD73, and CD44 mesenchymal stem cell markers (<50%)
but also showed positive expression for endothelial marker
CD31. Our results therefore suggest that while the use of
trypsin, collagenase type 1, and nonenzymatic harvest does
not affect the expression of mesenchymal stem cell markers
on hESCs’ cell surface in the early passages, the long-term
maintenance of mesenchymal surface markers could only
be achieved in cell isolation with collagenase type 1.
Reproductive medicine and stem cell research are two
areas known as nested. Endometrial stem cells can be
used for as therapeutics in reproductive sciences (Moore

et al., 2008; Mutlu et al., 2015). Reproductive medicine
applications intersect at three main points with stem cell
research: fertility preservation, the production of functional
gametes from stem cells, and the production of tissues and
organs to ensure fertility (Moore et al., 2008). As future
prospects, hESCs may therefore be considered as an easily
accessible source of mesenchymal stem cells. While we show
differences in the maintenance of mesenchymal stemness
in hESCs obtained using enzymatic and nonenzymatic
harvest of the endometrium, additional studies will be
needed to clarify the differences in the differentiation
potential of these cells into different lineages.
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